Literature DB >> 35220880

A defective lysophosphatidic acid-autophagy axis increases miscarriage risk by restricting decidual macrophage residence.

Hui-Li Yang1,2, Zhen-Zhen Lai1, Jia-Wei Shi1, Wen-Jie Zhou3, Jie Mei4, Jiang-Feng Ye5, Tao Zhang6, Jian Wang1, Jian-Yuan Zhao7,8, Da-Jin Li1, Ming-Qing Li1,2.   

Abstract

Massive infiltrated and enriched decidual macrophages (dMφ) have been widely regarded as important regulators of maternal-fetal immune tolerance and trophoblast invasion, contributing to normal pregnancy. However, the characteristics of metabolic profile and the underlying mechanism of dMφ residence remain largely unknown. Here, we observe that dMφ display an active glycerophospholipid metabolism. The activation of ENPP2-lysophosphatidic acid (LPA) facilitates the adhesion and retention, and M2 differentiation of dMφ during normal pregnancy. Mechanistically, this process is mediated through activation of the LPA receptors (LPAR1 and PPARG/PPARγ)-DDIT4-macroautophagy/autophagy axis, and further upregulation of multiple adhesion factors (e.g., cadherins and selectins) in a CLDN7 (claudin 7)-dependent manner. Additionally, poor trophoblast invasion and placenta development, and a high ratio of embryo loss are observed in Enpp2±, lpar1-/- or PPARG-blocked pregnant mice. Patients with unexplained spontaneous abortion display insufficient autophagy and cell residence of dMφ. In therapeutic studies, supplementation with LPA or the autophagy inducer rapamycin significantly promotes dMφ autophagy and cell residence, and improves embryo resorption in Enpp2± and spontaneous abortion mouse models, which should be dependent on the activation of DDIT4-autophagy-CLDN7-adhesion molecules axis. This observation reveals that inactivation of ENPP2-LPA metabolism and insufficient autophagy of dMφ result in resident obstacle of dMφ and further increase the risk of spontaneous abortion, and provides potential therapeutic strategies to prevent spontaneous abortion.Abbreviations: ACTB: actin beta; ADGRE1/F4/80: adhesion G protein-coupled receptor E1; Atg5: autophagy related 5; ATG13: autophagy related 13; BECN1: beclin 1; CDH1/E-cadherin: cadherin 1; CDH5/VE-cadherin: cadherin 5; CFSE: carboxyfluorescein succinimidyl ester; CLDN7: claudin 7; CSF1/M-CSF: colony stimulating factor 1; CSF2/GM-CSF: colony stimulating factor 2; Ctrl: control; CXCL10/IP-10: chemokine (C-X-C) ligand 10; DDIT4: DNA damage inducible transcript 4; dMφ: decidual macrophage; DSC: decidual stromal cells; ENPP2/ATX: ectonucleotide pyrophosphatase/phosphodiesterase 2; Enpp2±: Enpp2 heterozygous knockout mouse; ENPP2i/PF-8380: ENPP2 inhibitor; EPCAM: epithelial cell adhesion molecule; ESC: endometrial stromal cells; FGF2/b-FGF: fibroblast growth factor 2; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GPCPD1: glycerophosphocholine phosphodiesterase 1; HE: heterozygote; HIF1A: hypoxia inducible factor 1 subunit alpha; HNF4A: hepatocyte nuclear factor 4 alpha; HO: homozygote; ICAM2: intercellular adhesion molecule 2; IL: interleukin; ITGAV/CD51: integrin subunit alpha V; ITGAM/CD11b: integrin subunit alpha M; ITGAX/CD11b: integrin subunit alpha X; ITGB3/CD61: integrin subunit beta 3; KLRB1/NK1.1: killer cell lectin like receptor B1; KRT7/cytokeratin 7: keratin 7; LPA: lysophosphatidic acid; LPAR: lysophosphatidic acid receptor; lpar1-/-: lpar1 homozygous knockout mouse; LPAR1i/AM966: LPAR1 inhibitor; LY6C: lymphocyte antigen 6 complex, locus C1; LYPLA1: lysophospholipase 1; LYPLA2: lysophospholipase 2; Lyz2: lysozyme 2; MAP1LC3B: microtubule associated protein 1 light chain 3 beta; MARVELD2: MARVEL domain containing 2; 3-MA: 3-methyladenine; MBOAT2: membrane bound O-acyltransferase domain containing 2; MGLL: monoglyceride lipase; MRC1/CD206: mannose receptor C-type 1; MTOR: mechanistic target of rapamycin kinase; NP: normal pregnancy; PDGF: platelet derived growth factor; PLA1A: phospholipase A1 member A; PLA2G4A: phospholipase A2 group IVA; PLPP1: phospholipid phosphatase 1; pMo: peripheral blood monocytes; p-MTOR: phosphorylated MTOR; PPAR: peroxisome proliferator activated receptor; PPARG/PPARγ: peroxisome proliferator activated receptor gamma; PPARGi/GW9662: PPARG inhibitor; PTPRC/CD45: protein tyrosine phosphatase receptor type, C; Rapa: rapamycin; RHEB: Ras homolog, mTORC1 binding; SA: spontaneous abortion; SELE: selectin E; SELL: selectin L; siCLDN7: CLDN7-silenced; STAT: signal transducer and activator of transcription; SQSTM1: sequestosome 1; TJP1: tight junction protein 1; VCAM1: vascular cell adhesion molecule 1; WT: wild type.

Entities:  

Keywords:  Abortion; CLDN7; DDIT4; ENPP2; LPAR1; decidual macrophage; lysophosphatidic acid; trophoblast invasion

Mesh:

Substances:

Year:  2022        PMID: 35220880      PMCID: PMC9542369          DOI: 10.1080/15548627.2022.2039000

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   13.391


  63 in total

Review 1.  Growth control under stress: mTOR regulation through the REDD1-TSC pathway.

Authors:  Leif W Ellisen
Journal:  Cell Cycle       Date:  2005-11-01       Impact factor: 4.534

Review 2.  Immunology of the maternal-fetal interface.

Authors:  Adrian Erlebacher
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

3.  Intestinal deletion of Claudin-7 enhances paracellular organic solute flux and initiates colonic inflammation in mice.

Authors:  Hiroo Tanaka; Maki Takechi; Hiroshi Kiyonari; Go Shioi; Atsushi Tamura; Sachiko Tsukita
Journal:  Gut       Date:  2015-02-17       Impact factor: 23.059

Review 4.  Mechanisms of implantation: strategies for successful pregnancy.

Authors:  Jeeyeon Cha; Xiaofei Sun; Sudhansu K Dey
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

Review 5.  Itaconate: the poster child of metabolic reprogramming in macrophage function.

Authors:  Luke A J O'Neill; Maxim N Artyomov
Journal:  Nat Rev Immunol       Date:  2019-05       Impact factor: 53.106

6.  Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis.

Authors:  Berna Kaya; Cristian Doñas; Philipp Wuggenig; Oscar E Diaz; Rodrigo A Morales; Hassan Melhem; Pedro P Hernández; Tanay Kaymak; Srustidhar Das; Petr Hruz; Yannick Franc; Florian Geier; C Korcan Ayata; Eduardo J Villablanca; Jan Hendrik Niess
Journal:  Cell Rep       Date:  2020-08-04       Impact factor: 9.423

7.  The autophagy protein, FIP200 (RB1CC1) mediates progesterone responses governing uterine receptivity and decidualization†.

Authors:  Arin K Oestreich; Sangappa B Chadchan; Alexandra Medvedeva; John P Lydon; Emily S Jungheim; Kelle H Moley; Ramakrishna Kommagani
Journal:  Biol Reprod       Date:  2020-04-15       Impact factor: 4.285

Review 8.  Current concepts and new trends in the diagnosis and management of recurrent miscarriage.

Authors:  Jaume Alijotas-Reig; Carmen Garrido-Gimenez
Journal:  Obstet Gynecol Surv       Date:  2013-06       Impact factor: 2.347

9.  Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.

Authors:  Michael Friedrich; Christoforos K Vaxevanis; Katharina Biehl; Anja Mueller; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

10.  MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis.

Authors:  Rong Deng; Hai-Liang Zhang; Jun-Hao Huang; Rui-Zhao Cai; Yan Wang; Yu-Hong Chen; Bing-Xin Hu; Zhi-Peng Ye; Zhi-Ling Li; Jia Mai; Yun Huang; Xuan Li; Xiao-Dan Peng; Gong-Kan Feng; Jun-Dong Li; Jun Tang; Xiao-Feng Zhu
Journal:  Autophagy       Date:  2020-12-07       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.